Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0000899243-16-020912
Filing Date
2016-05-25
Accepted
2016-05-25 16:54:57
Documents
2
Period of Report
2016-05-25

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 3232
2 EX-24 DOCUMENT attachment1.htm EX-24 5223
  Complete submission text file 0000899243-16-020912.txt   9822
Mailing Address 2801 GATEWAY DRIVE SUITE 150 IRVING TX 75063
Business Address 2801 GATEWAY DRIVE SUITE 150 IRVING TX 75063 972-865-2206
REATA PHARMACEUTICALS INC (Issuer) CIK: 0001358762 (see all company filings)

EIN.: 113651945 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O REATA PHARMACEUTICALS, INC. 2801 GATEWAY DR. SUITE 150 IRVING TX 75063
Business Address
Stone Dennis K. (Reporting) CIK: 0001662323 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-37785 | Film No.: 161675227